Stocks
OPKO Health, Inc.OPK
NASDAQHealthcareBiotechnology$1.19+2.59%
A biopharmaceutical and diagnostics company, OPKO Health focuses on developing and commercializing novel therapies and diagnostic tests. Investors monitor its pipeline of treatments for conditions like chronic kidney disease and growth hormone deficiency, as well as its BioReference Laboratories subsidiary's diagnostic services.
Market Cap: $913.6M52W Range: $1.11 – $1.87
Congressional Interest in OPKO Health, Inc. (OPK)
1 member of Congress has disclosed 3 trades in OPKO Health, Inc. (OPK), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
3
Sells
0
Who in Congress Is Trading OPK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-09-26 | Carlos Curbelo | buy | $1K – $15K |
| 2017-03-02 | Carlos Curbelo | buy | $1K – $15K |